Lorad adapts DSM to upright mammography

Article

Mammography vendor Loradhas made advances in retrofitting its digital breast biopsy technologyto the StereoLoc upright needle biopsy system, according to presidentHal Kirshner. Lorad, of Danbury, CT, will display a version ofits DSM (digital spot

Mammography vendor Loradhas made advances in retrofitting its digital breast biopsy technologyto the StereoLoc upright needle biopsy system, according to presidentHal Kirshner. Lorad, of Danbury, CT, will display a version ofits DSM (digital spot mammography) device that has been adaptedto work with the StereoLoc biopsy guide on the M-III mammographyunit.

The adaptation will enable Lorad users to conduct digitallyguided needle biopsies with patients in the upright position.Using the DSM/StereoLoc/M-III combination will give mammographersmore flexibility in conducting breast biopsy procedures, Kirshnersaid. The combination also gives mammographers the advantage ofusing the motor-driven DSM system.

Lorad will also display the latest work on its full-breastdigital mammography system. The company will once again show awork-in-progress prototype in its exhibit booth, and will displayboth hard- and soft-copy images acquired with the system thatshow its penetration of dense breast tissue.

Recent Videos
New Mammography Studies Assess Image-Based AI Risk Models and Breast Arterial Calcification Detection
Can Deep Learning Provide a CT-Less Alternative for Attenuation Compensation with SPECT MPI?
Employing AI in Detecting Subdural Hematomas on Head CTs: An Interview with Jeremy Heit, MD, PhD
Pertinent Insights into the Imaging of Patients with Marfan Syndrome
What New Brain MRI Research Reveals About Cannabis Use and Working Memory Tasks
Current and Emerging Legislative Priorities for Radiology in 2025
How Will the New FDA Guidance Affect AI Software in Radiology?: An Interview with Nina Kottler, MD, Part 2
A Closer Look at the New Appropriate Use Criteria for Brain PET: An Interview with Phillip Kuo, MD, Part 2
How Will the New FDA Guidance Affect AI Software in Radiology?: An Interview with Nina Kottler, MD, Part 1
A Closer Look at the New Appropriate Use Criteria for Brain PET: An Interview with Phillip Kuo, MD, Part 1
Related Content
© 2025 MJH Life Sciences

All rights reserved.